MFDS — authorised 22 October 2012
- Marketing authorisation holder: EISAI INC
- Status: likely_approved
🇰🇷 Fycompa in South Korea
MFDS authorised Fycompa on 22 October 2012
Marketing authorisation
Fycompa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Fycompa approved in South Korea?
Yes. MFDS authorised it on 22 October 2012.
Who is the marketing authorisation holder for Fycompa in South Korea?
EISAI INC holds the South Korean marketing authorisation.